The role of T cells in allografted tumor rejection: IFN-γ released from T cells is essential for induction of effector macrophages in the rejection site

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 6012-6017

  Yoneda, Yukio ^a,b   Yoshida, Ryotaro ^a,c  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b Shiga 525 0055   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER TRANSPLANTATION; CYTOTOXICITY; FIBROSARCOMA; INTERFERON PRODUCTION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; FIBROSARCOMA; GRAFT REJECTION; INTERFERON TYPE II; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES;

EID: 0032526589     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hall, B. M. 1991. Cells mediating allograft rejection. Transplantation 51:1141.
2. b mutant skin allografts differing in class I MHC. Nature 322:829.
3. + helper T cells recognizing class II alloantigens. J. Immunol. 144:2425.
4. Yoshida, R., S. W. Park, H. Yasui, and O. Takikawa. 1988. Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 141:2819.
5. Yoshida, R., O. Takikawa, T. Oku, and A. Habara-Ohkubo. 1991. Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc. Natl. Acad. Sci. USA 88:1526.
6. Yoshida, R., A. Matsuura, K. Einaga, Y. Ushio, N. Yamamoto, and Y. Yoneda. 1997. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol. Immunol. 41:149.
7. Ushio, Y., N. Yamamoto, A. Sanchez-Bueno, and R. Yoshida. 1996. Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol. Immunol. 40:489.
8. Ushio-Umeda, Y., and R. Yoshida. 1997. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage. Microbiol. Immunol. 41:981.
9. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
10. 2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. J. Immunol. 159:15.
11. Zijlstra, M., H. J. Auchincloss, J. Loring, C. Chase, P. Russell, and R. Jaenisch. 1992. Skin graft rejection by beta 2-microglobulin-deficient mice. J. Exp. Med. 175:885.
12. -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 156:4114.
13. Van Buskirk, A., M. Wakely, and C. Orosz. 1996. Acute rejection of cardiac allografts by noncytolytic CD4 (+) T cell populations. Transplantation 62:300.
14. + cells are essential for allorejection. J. Exp. Med. 184:2013.
15. Yamamoto, N., K. Einaga-Naito, M. Kuriyama, Y. Kawada, and R. Yoshida. 1998. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation. 65:818.
16. Sanchez-Bueno, A., V. Verkhusha, Y. Tanaka, O. Takikawa, and R. Yoshida. 1996. Interferon-γ-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-γ-inducing factor in macrophages elicited by allografted tumor cells. Biochem. Biophys. Res. Commun. 224:555.
17. Celada, A., and C. Nathan. 1994. Macrophage activation revisited. Immunol. Today 15:100.
18. Lynn, W. A., and D. T. Golenbock. 1992. Lipopolysaccharide antagonists. Immunol. Today 13:271.
19. Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13:265.
20. Klein, E., and A. Mantovani. 1993. Action of natural killer cells and macrophages in cancer. Curr. Opin. Immunol. 5:714.
21. Stout, R. D. 1993. Macrophage activation by T cells: cognate and non-cognate signals. Curr. Opin. Immunol. 5:398.
22. Singh, R. K., K. Berry, K. Matsushima, K. Yasumoto, and I. J. Fidler. 1993. Synergism between human monocyte chemotactic and activating factor and bacterial products for activation of tumoricidal properties in murine macrophages. J. Immunol. 151:2786.
23. Philip, R., and L. B. Epstein. 1986. Tumor necrosis factor as immunomodulator and mediator of monocyte cytoloxicity induced by itself, γ-interferon and interleukin-1. Nature 323:86.
24. Takikawa, O., T. Oku, H. Yasui, and R. Yoshida. 1993. Synergism between IFN-γ and IL-1α/β in growth inhibition of an allografted tumor. J. Immunol. 151:2070.
25. Tagawa, Y., K. Sekikawa, and Y. Iwakura. 1997. Suppression of concanavalin A-induced hepatitis in IFN-γ -/- mice, but not in TNF-α -/- mice. J. Immunol. 159:1418.
26. Yoshimoto, T., H. Okamura, Y. Tagawa, Y. Iwakura, and K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. USA 94:3948.
27. Capalbo, E. E., J. F. Albright, and W. E. Bennett. 1964. Evaluation of the diffusion chamber culture technique for study of the morphological and functional characteristics of lymphoid cells during antibody production. J. Immunol. 92:243.
28. - T cells. J. Immunol. 135:2187.
29. Ascher, N. L., R. M. Ferguson, R. Hoffman, and R. L. Simmons. 1979. Partial characterization of cytotoxic cells infiltrating sponge matrix. Transplantation 27:254.
30. Christmas, S. E., and G. G. MacPherson. 1982. The role of mononuclear phagocytes in cardiac allograft rejection in the rat. III. The effect of cells extracted from rat cardiac allografts upon beating heart cell cultures. Cell. Immunol. 69:281.
31. Gassel, A. M., M. -L. Hansmann, H. -J. Radzun, and M. Weyand. 1990. Human cardiac allograft rejection: correlation of grading with expression of different monocyte/macrophage markers. Am. J. Clin. Pathol. 94:274.
32. Hancock, W. W., N. M. Thomson, and R. C. Atkins. 1983. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 35:458.
33. + T lymphocytes in primary nonfuncuon and classic rejection of islet allografts. J. Exp. Med. 172:291.
34. Mayer, T. G., A. K. Bahnand, and H. J. Winn. 1988. Immunohistochemical analyses of skin graft rejection in mice: kinetics of lymphocyte infiltration in grafts of limited immunogenetic disparity. Transplantation 46:890.
35. Alexander, D. Z., T. C. Pearson, R. Hendrix, S. C. Ritchie, and C. P. Larsen. 1996. Analysis of effector mechanisms in murine cardiac allograft rejection. Transplant. Immunol. 4:46.
36. Armstrong, J. W., and S. K. Chapes. 1994. Effects of extracellular matrix proteins on macrophage differentiation, growth, and function: comparison of liquid and agar culture systems. J. Exp. Zool. 269:178.
37. Kaplan, G. 1983. In vitro differentiation of human monocytes: monocytes cultured on glass are cytotoxic to tumor cells but monocytes cultured on collagen are not. J. Exp. Med. 157:2061.
38. Sporn, S. A., D. F. Eierman, C. E. Johnson, J. Morris, G. Martin, M. Lander, and S. Haskill. 1990. Monocyte adherence results in selective induction of novel genes sharing homology with mediators of inflammation and tissue repair. J. Immunol. 144:4434.
39. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
40. Saleem, S., B. T. Konieczny, R. P. Lowry, F. K. Baddoura, and F. G. Lakkis. 1996. Acute rejection of vascularized heart allografts in the absence of IFN-γ. Transplantation 62:1908.
41. Takikawa, O., A. Habara-Ohkubo, and R. Yoshida. 1990. IFN-γ is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J. Immunol. 145:1246.